Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,117
Closed -$802K 199
2025
Q4
$802K Hold
4,117
0.01% 120
2025
Q3
$1.16M Sell
4,117
-200
-5% -$50.9K 0.02% 105
2025
Q2
$944K Sell
4,317
-57
-1% -$9.2K 0.02% 110
2025
Q1
$612K Buy
4,374
+357
+9% +$58.1K 0.01% 126
2024
Q4
$669K Buy
+4,017
New +$714K 0.01% 121
2019
Q4
Sell
-5,215
Closed -$287K 220
2019
Q3
$287K Buy
+5,215
New +$288K 0.01% 175
2015
Q4
Sell
-5,546
Closed -$200K 312
2015
Q3
$200K Sell
5,546
-160
-3% -$6.15K 0.01% 295
2015
Q2
$230K Sell
5,706
-2,000
-26% -$86.7K 0.01% 308
2015
Q1
$333K Buy
7,706
+173
+2% +$7.5K 0.01% 268
2014
Q4
$339K Sell
7,533
-440
-6% -$17.9K 0.01% 272
2014
Q3
$305K Buy
7,973
+160
+2% +$6.48K 0.01% 284
2014
Q2
$317K Buy
7,813
+300
+4% +$12.3K 0.01% 289
2014
Q1
$307K Hold
7,513
0.01% 278
2013
Q4
$287K Buy
+7,513
New +$258K 0.01% 292
2013
Q3
Sell
-11,113
Closed -$341K 358
2013
Q2
$341K Buy
+11,113
New +$369K 0.01% 261

Other funds holding ORCL

Beck Mack & Oliver's ORCL Position: Q1 2026 in Review

Beck Mack & Oliver sold out of Oracle (ORCL) in Q1 2026, closing a stake of 4,117 shares — an estimated $802K sold.

Beck Mack & Oliver first reported a position in ORCL in Q2 2013 and held it in 15 quarters. The position peaked at $1.16M in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Beck Mack & Oliver reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Beck Mack & Oliver sold 4,117 Oracle shares in Q1 2026, an estimated $802K.
  • Beck Mack & Oliver first reported a position in Oracle in Q2 2013 and held it in 15 quarters.
  • Beck Mack & Oliver's Oracle position peaked at $1.16M in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.